Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 122 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
19 Sep 2023
10% owner
Sold at will
32,167
$850.94K
100%
18 Sep 2023
10% owner indirect
Sold at will
30,292
$705.65K
85.8%
18 Sep 2023
Director
Sold at will
3,334
$83.32K
0.7%
15 Sep 2023
VP, Clinical Trial Operations
Sold at will
10,400
$227.63K
8.9%
15 Sep 2023
Director
Sold at will
3,333
$73.00K
0.7%
14 Sep 2023
10% owner indirect
Sold at will
25,276
$557.81K
41.7%
13 Sep 2023
VP, Clinical Trial Operations
Sold at will
29,800
$629.93K
21.9%
13 Sep 2023
10% owner indirect
Sold at will
19,032
$408.09K
23.9%
13 Sep 2023
Director
Sold at will
900
$18.70K
11.5%
12 Sep 2023
10% owner indirect
Sold at will
20,265
$451.17K
20.3%
11 Sep 2023
10% owner indirect
Sold at will
32,351
$718.70K
24.5%
8 Sep 2023
10% owner indirect
Sold at will
24,831
$575.33K
15.8%
7 Sep 2023
10% owner indirect
Sold at will
12,446
$303.27K
7.3%
30 Aug 2023
VP, Clinical Trial Operations
Sold at will
19,800
$489.06K
12.7%
18 Aug 2023
President and CEO
Sold at will
8,349
$198.12K
36.3%
18 Aug 2023
VP, Pharmaceutical Development
Sold at will
3,265
$77.48K
36.3%
18 Aug 2023
VP, Clinical Trial Operations
Sold at will
3,265
$77.48K
2.1%
18 Aug 2023
Chief Financial Officer
Sold at will
1,297
$30.78K
36.0%
18 Aug 2023
Head of Regulatory
Sold at will
935
$22.19K
31.2%
18 Aug 2023
Head of Quality
Sold at will
515
$12.22K
31.2%
18 Aug 2023
General Counsel
Sold at will
328
$7.78K
36.4%
26 Jan 2023
Associate VP, Research indirect
Bought
200
$1.25K
opened
Showing 101–122 of 122. ← Newer Page 3 of 3